InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（30 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
30
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Anzalone Christopher Richard, 首席执行官. Insider active across 2 companies, notably Arrowhead Pharmaceuticals, INC.. In total, 50 filings have been recorded. Breakdown: 0 buy · 30 sells. Total volume traded: €22.4m. Activity tracked since 20 October 2021. The latest transaction was filed on 2 January 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Anzalone Christopher Richard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报50 总计
7,416 股@ US$65.880.0039% mcap3.4% 占其流量Common StockSEC:0001423029-26-000001:0
35,181 股@ US$6.150.0017% mcap1.5% 占其流量Common StockSEC:0001423029-25-000009:0
16,545 股@ US$6.150.3% 占其流量Common StockSEC:0001423029-25-000009:1
35,181 股@ US$69.336.3% 占其流量Common StockSEC:0001423029-25-000009:2
16,545 股@ US$68.692.9% 占其流量Common StockSEC:0001423029-25-000009:3
3,979 股@ US$66.670.0021% mcap1.8% 占其流量Common StockSEC:0001423029-25-000007:0
8,147 股@ US$68.011.4% 占其流量Common StockSEC:0001423029-25-000007:1
1,319 股@ US$68.480.2% 占其流量Common StockSEC:0001423029-25-000007:2
10,012 股@ US$68.331.8% 占其流量Common StockSEC:0001423029-25-000007:3
2,574 股@ US$68.850.5% 占其流量Common StockSEC:0001423029-25-000007:4
46,287 股@ US$63.550.023% mcap20.4% 占其流量Common StockSEC:0001423029-25-000005:0
180,000 股0Common StockSEC:0001423029-25-000003:0
100,532 股@ US$68.6717.8% 占其流量Common StockSEC:0001423029-25-000003:1
21,321 股@ US$69.283.8% 占其流量Common StockSEC:0001423029-25-000003:2
8,147 股@ US$69.961.5% 占其流量Common StockSEC:0001423029-25-000003:3
8,416 股@ US$60.511.3% 占其流量Common StockSEC:0001423029-25-000003:4
10,963 股@ US$61.251.7% 占其流量Common StockSEC:0001423029-25-000003:5
14,095 股@ US$62.122.3% 占其流量Common StockSEC:0001423029-25-000003:6
8,476 股@ US$62.941.4% 占其流量Common StockSEC:0001423029-25-000003:7
6,661 股@ US$64.291.1% 占其流量Common StockSEC:0001423029-25-000003:8
1,000 股@ US$64.960.2% 占其流量Common StockSEC:0001423029-25-000003:9
1,300 股@ US$65.770.2% 占其流量Common StockSEC:0001423029-25-000003:10
166 股@ US$66.770.0% 占其流量Common StockSEC:0001423029-25-000003:11
3,221 股@ US$67.870.6% 占其流量Common StockSEC:0001423029-25-000003:12
35,305 股@ US$9.931.0% 占其流量Common StockSEC:0001628280-25-017592:0
50 条申报中的 25 条
About Anzalone Christopher Richard
Anzalone Christopher Richard is Chief Executive Officer at Arrowhead Pharmaceuticals, INC. and ARROWHEAD RESEARCH CORP. He has made 50 filings in total, and across the 50 recent filings sampled, they show EUR 22,372,625 of sales between 2016-01-04 and 2026-01-05.
